SEC Filing Alert: Quince Therapeutics, Inc. (0001662774) (Filer) Files 8-K — 2026-06-26
Quince Therapeutics 8-K Filing: Material Changes to Corporate Structure On June 26, 2026, Quince Therapeutics, Inc. (ticker: QUIN) filed a Form 8-K with the Securities and Exchange Commission, signaling material changes to the company's corporate governance and shareholder rights. For retail investors and financial professionals monitoring